{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:55:49Z","timestamp":1789707349660,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ijpharm.2006.09.003","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T11:12:21Z","timestamp":1157973141000},"page":"105-113","source":"Crossref","is-referenced-by-count":27,"title":["Solubility measurement of polymorphic compounds via the pH-metric titration technique"],"prefix":"10.1016","volume":"330","author":[{"given":"Ann F.","family":"Fioritto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobha N.","family":"Bhattachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Wesley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.09.003_bib1","first-page":"25","article-title":"Optimization of furosemide tablets, part 2: polymorphism of furosemide","volume":"35","author":"Abdallah","year":"1989","journal-title":"Acta Pharm. Tech."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jps.2600780416","article-title":"Polymorphism of sulfathiazole","volume":"78","author":"Anwar","year":"1989","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib3","first-page":"165","article-title":"pH-metric solubility. 1. Solubility-pH profiles from Bjerrum plots. Gibbs buffer and pKa in the solid state","volume":"4","author":"Avdeef","year":"1998","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0928-0987(01)00190-7","article-title":"pH-metric solubility. 3. Dissolution titration template method for solubility determination","volume":"14","author":"Avdeef","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1007526826979","article-title":"pH-metric solubility. 2. Correlation between the acid\u2013base titration and the saturation shake-flask solubility pH methods","volume":"17","author":"Avdeef","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib6","first-page":"152","article-title":"Polymorphism of oral antidiabetics. 1. Chlorpropamide","volume":"43","author":"Burger","year":"1975","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib7","first-page":"1","article-title":"Interpretation of polymorphism studies","volume":"28","author":"Burger","year":"1982","journal-title":"Acta Pharm. Tech."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib8","series-title":"Pharmaceutical Statistics, Practical and Clinical Applications","first-page":"355","article-title":"Transformations and outliers","author":"Bolton","year":"1997"},{"key":"10.1016\/j.ijpharm.2006.09.003_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01979491","article-title":"Preparation and physical characterization of forms II and III of paracetamol","volume":"48","author":"Di Martino","year":"1997","journal-title":"J. Therm. Anal."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.20212","article-title":"Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid\/base titrations and calculated solubilities","volume":"94","author":"Glomme","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib11","first-page":"1071","article-title":"The physical instability of sulfamethoxazole aqueous suspension","volume":"44","author":"Graf","year":"1982","journal-title":"Pharm. Ind."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1021\/js960264c","article-title":"The polymorphic drug substances of the European Pharmacopoeia. Part 9. Physiochemical properties and crystal structure of acetazolamide crystal forms","volume":"86","author":"Griesser","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(92)90145-R","article-title":"Diffuse reflectance infrared Fourier transform spectroscopy for the quantitative analysis of mixtures of polymorphs","volume":"85","author":"Hartauer","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib14","doi-asserted-by":"crossref","first-page":"B90","DOI":"10.1088\/0022-3727\/26\/8B\/013","article-title":"Crystallization of polymorphs: the effect of solvent","volume":"26","author":"Khoshkhoo","year":"1993","journal-title":"J. Phys. D: Appl. Phys."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/3527601473.ch9","article-title":"Aqueous solubility in discovery, chemistry, and assay changes (drug bioavailability)","volume":"18","author":"Lipinski","year":"2003","journal-title":"Meth. Prin. Med. Chem."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1081\/PDT-100100538","article-title":"Quantifying crystalline form composition in binary powder mixtures using near-infrared reflectance spectroscopy","volume":"5","author":"Luner","year":"2000","journal-title":"Pharm. Dev. Tech."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(90)90185-7","article-title":"Physiochemical characterization of furosemide modifications","volume":"60","author":"Matsuda","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib18","first-page":"291","article-title":"Identifying the stable polymorph early in the drug discovery-development process","volume":"10","author":"Miller","year":"2005","journal-title":"Pharm. Dev. Tech."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib19","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1073\/pnas.0437744100","article-title":"Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization","volume":"100","author":"Morissette","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1021\/js970483d","article-title":"Physiochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution","volume":"87","author":"Nichols","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib21","first-page":"1","article-title":"Acetazolamide","volume":"vol. 22","author":"Parasrampuria","year":"1993"},{"key":"10.1016\/j.ijpharm.2006.09.003_bib22","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/ja042561m","article-title":"Crystalline polymorph selection and discovery with polymer heteronuclei","volume":"127","author":"Price","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jps.20302","article-title":"Trends in solubility of polymorphs","volume":"94","author":"Pudipeddi","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/js970063o","article-title":"Characterization and interconversion of polymorphs of premafloxacin, a new quinolone antibiotic","volume":"86","author":"Schinzer","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib25","first-page":"125","article-title":"Polymorphism in pharmaceuticals III: chlorpropamide","volume":"8","author":"Simmons","year":"1973","journal-title":"Can. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib26","first-page":"97","article-title":"Study on the polymorphism of acetaminophen","volume":"20","author":"Sohn","year":"1990","journal-title":"J. Korean Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib27","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1023\/A:1018934417124","article-title":"The qualitative and quantitative analysis of chlorpropamide polymorphic mixtures by near-infrared Fourier transform Raman spectroscopy","volume":"10","author":"Tudor","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib28","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1248\/cpb.33.3422","article-title":"Physio-chemical properties and isothermal transition of acetazolamide polymorphs","volume":"33","author":"Umeda","year":"1985","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jps.2600610104","article-title":"Polymorphism in sulfonamides","volume":"61","author":"Yang","year":"1972","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jps.2600840812","article-title":"Inferring thermodynamic stability relationship of polymorphs from melting data","volume":"84","author":"Yu","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.09.003_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jps.20275","article-title":"Rapid pKa estimation using vacuum-assisted multiplexed capillary electrophoresis (VAMCE) with ultraviolet detection","volume":"94","author":"Zhou","year":"2005","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306007368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306007368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T11:00:12Z","timestamp":1547377212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306007368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0378517306007368"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.09.003","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}